Lip GYH - Search Results

1

Efficacy and Safety of the Use of Non-vitamin K Antagonist Oral Anticoagulants in Patients with Ischemic Heart Disease: A Meta-Analysis of Phase III Randomized Trials.

Fu L, Zhu W, Huang L, Hu J, Ma J, Lip GYH, Hong K. Fu L, et al. Among authors: lip gyh. Am J Cardiovasc Drugs. 2019 Feb;19(1):37-47. doi: 10.1007/s40256-018-0299-7. Am J Cardiovasc Drugs. 2019. PMID: 30182350

2

Novel oral anticoagulants.

Khoo CW, Tay KH, Shantsila E, Lip GY. Khoo CW, et al. Int J Clin Pract. 2009 Apr;63(4):630-41. doi: 10.1111/j.1742-1241.2009.02011.x. Epub 2009 Feb 16. Int J Clin Pract. 2009. PMID: 19222611 Review.

3

Antithrombotic therapy for heart failure in sinus rhythm.

Subramaniam V, Davis RC, Shantsila E, Lip GY. Subramaniam V, et al. Fundam Clin Pharmacol. 2009 Dec;23(6):705-17. doi: 10.1111/j.1472-8206.2009.00776.x. Epub 2009 Sep 4. Fundam Clin Pharmacol. 2009. PMID: 19735305 Review.

4

The quest for new anticoagulants: from clinical development to clinical practice.

Apostolakis S, Lip GY, Lane DA, Shantsila E. Apostolakis S, et al. Cardiovasc Ther. 2011 Dec;29(6):e12-22. doi: 10.1111/j.1755-5922.2010.00160.x. Epub 2010 Jun 14. Cardiovasc Ther. 2011. PMID: 20553291 Free article. Review.

5

Does warfarin for stroke thromboprophylaxis protect against MI in atrial fibrillation patients?

Lip GY, Lane DA. Lip GY, et al. Am J Med. 2010 Sep;123(9):785-9. doi: 10.1016/j.amjmed.2010.01.031. Epub 2010 Jul 23. Am J Med. 2010. PMID: 20655037 Review.

6

Stroke prevention in atrial fibrillation patients.

Marinigh R, Lip GY, Lane DA. Marinigh R, et al. Expert Opin Pharmacother. 2010 Oct;11(14):2331-50. doi: 10.1517/14656566.2010.498819. Expert Opin Pharmacother. 2010. PMID: 20718589 Review.

7

Antiplatelet agents and anticoagulants for hypertension.

Lip GY, Felmeden DC, Dwivedi G. Lip GY, et al. Cochrane Database Syst Rev. 2011 Dec 7;2011(12):CD003186. doi: 10.1002/14651858.CD003186.pub3. Cochrane Database Syst Rev. 2011. Update in: Cochrane Database Syst Rev. 2022 Jul 28;7:CD003186. doi: 10.1002/14651858.CD003186.pub4 PMID: 22161375 Free PMC article. Updated. Review.

8

Net clinical benefit of new oral anticoagulants (dabigatran, rivaroxaban, apixaban) versus no treatment in a 'real world' atrial fibrillation population: a modelling analysis based on a nationwide cohort study.

Banerjee A, Lane DA, Torp-Pedersen C, Lip GY. Banerjee A, et al. Thromb Haemost. 2012 Mar;107(3):584-9. doi: 10.1160/TH11-11-0784. Epub 2011 Dec 21. Thromb Haemost. 2012. PMID: 22186961

9

Indirect comparisons of new oral anticoagulant drugs for efficacy and safety when used for stroke prevention in atrial fibrillation.

Lip GY, Larsen TB, Skjøth F, Rasmussen LH. Lip GY, et al. J Am Coll Cardiol. 2012 Aug 21;60(8):738-46. doi: 10.1016/j.jacc.2012.03.019. Epub 2012 May 9. J Am Coll Cardiol. 2012. PMID: 22575324 Free article.

10

Novel oral anticoagulants: focus on the direct factor Xa inhibitor darexaban.

Apostolakis S, Lip GY. Apostolakis S, et al. Expert Opin Investig Drugs. 2012 Jul;21(7):1057-64. doi: 10.1517/13543784.2012.689286. Epub 2012 May 23. Expert Opin Investig Drugs. 2012. PMID: 22616561 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,639 results

Search Page

Filters